Web4. mar 2024 · Penta-refractory MM was defined as refractoriness to those four agents in addition to daratumumab. Bendamustine was generally administered intravenously in the outpatient clinic at a dose of 90 mg/m 2 on days 1 and 2 of a 28-day cycle with oral prednisone on days 1 through 4. Web23. nov 2024 · Pts with triple-class refractory disease (refractory to one class of the following: immunomodulatory agents (IMiDs), proteasome inhibitors (PI) and anti-CD38 monoclonal antibody) have a poor prognosis. Belantamab mafodotin is a rst-in class B-cell maturation antigen (BCMA) antibody-drug conjugate.
Inferior Outcomes of Patients with Quad and Penta-Refractory …
Web4. jan 2024 · Patients who are triple- and quad-refractory have a median OS of less than 9.2 months, and patients who are penta-refractory have a median OS of 5.6 months. Penta … Web29. nov 2024 · Introduction: Despite the recent introduction of novel agents for multiple myeloma (MM), the disease remains incurable and invariably progresses through these new therapies. Patients with quad-refractory MM (refractory to bortezomib, carfilzomib, lenalidomide, and pomalidomide) and penta-refractory MM (refractory to an anti-CD38 … how to draw ruffles
refractory - Wiktionary
Webrefractory (100%) and penta-refractory (40%; defined as refractory to 1 monoclonal antibody, 2 PIs, and 2 IMiDs) MM.23 In patients with MM refractory to CD38 monoclonal … Web13. jan 2015 · Refractory is defined as ≤ 25% response to therapy, or progression during therapy or progression within 60 days after completion of therapy. Exclusion Criteria: Active smoldering MM. Active plasma cell leukemia. Documented systemic amyloid light chain amyloidosis. Active CNS MM. Contacts and Locations Go to Web5. nov 2024 · Penta or quad refractory was defined as having stable disease (as best response) or progressive disease while on all of the above drugs, per International … leawo abema